Atlas Trials

Open Label Clinical Trial of Intravenous Crotoxin Part 3

Clinical trial NCT01481532 · NOT_YET_RECRUITING

Trial details

NCT number
NCT01481532
Sponsor
Celtic Biotech Ltd
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Cancer
Start date
2026-10-01
Primary completion
2027-10-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.